|
|
|
 |
Welcome to the New FSRC Website!
|
** To view upcoming live CEU events, Click Here
|
|
CONGRATULATIONS FLORIDA!!! SCORE- Florida: 1400+ Emails-Next Closest State: 260 Emails
The Medicare RT Initiative Virtual Lobby Day was a huge success and you are NUMBER ONE!!!
Click Here to find out what's next for OUR initiative.
|
|
Our next challenge---Screen 50,000 adult Floridians for COPD by 11/15/10. Completing this simple 5 question form takes literally 2 minutes.
BONUS: Participants are invited to enter a drawing for a NASCAR vacation. If each of us screens just 10 adults, Florida will prevail in this State competition. Please click on the icon for additional information and the screener. Tell your church group, family, friends and co-workers to do the same: their lives may depend on it.
|   |
|
|
| Nomination forms
are now being accepted for FSRC Board Positions
|
|
| FSRC Scholarship Award Applications
will be accepted through October 1, 2010
|
|
Happenings in Respiratory Therapy
Florida DOH H1N1 After Action Report
Oil Spill Fact Sheet: Gulf Coast Oil Spill Fact Sheet for Health Care Providers: Florida DOH
FSRC Statement: SB1986, New Law Prohibiting Respiratory Licensure Renewal
BORC Position: NBRC Continuing Competency Program
FSRC Upcoming Board Meeting: August 20, 2010; Orlando, FL
BORC Upcoming Board Meeting: October 8, 2010; Orlando, FL
CE Broker: Origin, Function and FAQ's
CE Broker FSRC Member Discount
AARC / FSRC Membership at a Discount
--------------------------------------------------------------------------------
Get Involved!
Contact your Chapter Director and ask about the FSRC
Ambassador Program.
--------------------------------------------------------------------------------
The Florida Society for Respiratory Care and/or any official agent has no real or perceived conflicts of interest relating to emergency preparedness and/or mechanical ventilation. All work relating to emergency preparedness and/or mechanical ventilation is rendered as advisory only and does not show preference to any one company or product. The organization or agent shall disclose any apparent conflicts regarding financial interest in a product or drug; and/or, any discussion regarding utilization of FDA drugs or devices not within the approved regulations prior to working in this capacity. Public disclosure of information relating to advice given to outside parties will be prefaced with disclosure information."
|
|
